000181308 001__ 181308
000181308 005__ 20240229145645.0
000181308 0247_ $$2doi$$a10.1002/mp.15930
000181308 0247_ $$2pmid$$apmid:35982630
000181308 0247_ $$2ISSN$$a0094-2405
000181308 0247_ $$2ISSN$$a1522-8541
000181308 0247_ $$2ISSN$$a2473-4209
000181308 0247_ $$2altmetric$$aaltmetric:134732265
000181308 037__ $$aDKFZ-2022-01935
000181308 041__ $$aEnglish
000181308 082__ $$a610
000181308 1001_ $$aThummerer, Adrian$$b0
000181308 245__ $$aDeep learning based 4D-synthetic CTs from sparse-view CBCTs for dose calculations in adaptive proton therapy.
000181308 260__ $$aCollege Park, Md.$$bAAPM$$c2022
000181308 3367_ $$2DRIVER$$aarticle
000181308 3367_ $$2DataCite$$aOutput Types/Journal article
000181308 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670586543_24789
000181308 3367_ $$2BibTeX$$aARTICLE
000181308 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181308 3367_ $$00$$2EndNote$$aJournal Article
000181308 500__ $$a2022 Nov;49(11):6824-6839
000181308 520__ $$aTime resolved 4D cone beam computed tomography (4D-CBCT) allows a daily assessment of patient anatomy and respiratory motion. However, 4D-CBCTs suffer from imaging artifacts that affect the CT number accuracy and prevent accurate proton dose calculations. Deep learning can be used to correct CT numbers and generate synthetic CTs which can enable CBCT-based proton dose calculations.In this work, sparse view 4D-CBCTs were converted into 4D synthetic CTs (4D-sCT) utilizing a deep convolutional neural network (DCNN). 4D-sCTs were evaluated in terms of image quality and dosimetric accuracy to determine if accurate proton dose calculations for adaptive proton therapy workflows of lung cancer patients are feasible.A dataset of 45 thoracic cancer patients was utilized to train and evaluate a DCNN to generate 4D-sCTs, based on sparse view 4D-CBCTs reconstructed from projections acquired with a 3D acquisition protocol. Mean absolute error (MAE) and mean error (ME) were used as metrics to evaluate image quality of single phases and average 4D-sCTs against 4D-CTs acquired on the same day. The dosimetric accuracy was checked globally (gamma analysis) and locally for target volumes and organs at risk (lung, heart, and esophagus). Furthermore, 4D-sCTs were also compared to 3D-sCTs. To evaluate CT number accuracy, proton radiography simulations in 4D-sCT and 4D-CTs were compared in terms of range errors. The clinical suitability of 4D-sCTs was demonstrated by performing a 4D dose reconstruction using patient specific treatment delivery log-files and breathing signals.4D-sCTs resulted in average MAEs of 48.1 ± 6.5 HU (single phase) and 37.7 ± 6.2 HU (average). The global dosimetric evaluation showed gamma pass ratios of 92.3 ± 3.2 % (single phase) and 94.4 ± 2.1 % (average). The target volume (CTV) showed high agreement in D98 between 4D-CT and 4D-sCT, with differences below 2.4% for all patients. Larger dose differences were observed in mean doses of organs-at-risk (up to 8.4%). The comparison with 3D-sCTs showed no substantial image quality and dosimetric differences for the 4D-sCT average. Individual 4D-sCT phases showed slightly lower dosimetric accuracy. The range error evaluation revealed that lung tissues cause range errors about 3 times higher than the other tissues.In this study, we have investigated the accuracy of deep learning based 4D-sCTs for daily dose calculations in adaptive proton therapy. Despite image quality differences between 4D-sCTs and 3D-sCTs, comparable dosimetric accuracy was observed globally and locally. Further improvement of 3D and 4D lung sCTs could be achieved by increasing CT number accuracy in lung tissues. This article is protected by copyright. All rights reserved.
000181308 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000181308 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181308 650_7 $$2Other$$a4D imaging
000181308 650_7 $$2Other$$aadaptive proton therapy
000181308 650_7 $$2Other$$adeep learning
000181308 650_7 $$2Other$$asynthetic CT
000181308 7001_ $$aOria, Carmen Seller$$b1
000181308 7001_ $$aZaffino, Paolo$$b2
000181308 7001_ $$aVisser, Sabine$$b3
000181308 7001_ $$aMeijers, Arturs$$b4
000181308 7001_ $$aMarmitt, Gabriel Guterres$$b5
000181308 7001_ $$aWijsman, Robin$$b6
000181308 7001_ $$0P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aSeco, Joao$$b7$$udkfz
000181308 7001_ $$aLangendijk, Johannes Albertus$$b8
000181308 7001_ $$aKnopf, Antje Christin$$b9
000181308 7001_ $$aSpadea, Maria Francesca$$b10
000181308 7001_ $$aBoth, Stefan$$b11
000181308 773__ $$0PERI:(DE-600)1466421-5$$a10.1002/mp.15930$$gp. mp.15930$$n11$$p6824-6839$$tMedical physics$$v49$$x0094-2405$$y2022
000181308 909CO $$ooai:inrepo02.dkfz.de:181308$$pVDB
000181308 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000181308 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000181308 9141_ $$y2022
000181308 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-02-02$$wger
000181308 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000181308 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000181308 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMED PHYS : 2021$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-12
000181308 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-12
000181308 9201_ $$0I:(DE-He78)E041-20160331$$kE041$$lE041 Med. Physik in der Radioonkologie$$x0
000181308 980__ $$ajournal
000181308 980__ $$aVDB
000181308 980__ $$aI:(DE-He78)E041-20160331
000181308 980__ $$aUNRESTRICTED